1. Home
  2. CNET vs ONCO Comparison

CNET vs ONCO Comparison

Compare CNET & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZW Data Action Technologies Inc.

CNET

ZW Data Action Technologies Inc.

HOLD

Current Price

$0.69

Market Cap

2.4M

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$0.62

Market Cap

2.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNET
ONCO
Founded
2003
2018
Country
Hong Kong
United States
Employees
25
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.3M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
CNET
ONCO
Price
$0.69
$0.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.2K
341.3K
Earning Date
04-14-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.80
EPS
N/A
N/A
Revenue
$46,633,000.00
$815,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
34.20
N/A
52 Week Low
$0.60
$0.05
52 Week High
$2.78
$7.65

Technical Indicators

Market Signals
Indicator
CNET
ONCO
Relative Strength Index (RSI) 38.23 35.74
Support Level $0.60 $0.45
Resistance Level $0.86 $0.95
Average True Range (ATR) 0.06 0.09
MACD 0.01 0.02
Stochastic Oscillator 6.58 11.84

Price Performance

Historical Comparison
CNET
ONCO

About CNET ZW Data Action Technologies Inc.

ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: